GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » Days Sales Outstanding

Zylox-Tonbridge Medical Technology Co (FRA:818) Days Sales Outstanding : 0.75 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Days Sales Outstanding?

Zylox-Tonbridge Medical Technology Co's average Accounts Receivable for the six months ended in Jun. 2024 was €0.19 Mil. Zylox-Tonbridge Medical Technology Co's Revenue for the six months ended in Jun. 2024 was €46.87 Mil. Hence, Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 0.75.

The historical rank and industry rank for Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding or its related term are showing as below:

FRA:818' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.59   Med: 0.82   Max: 75.19
Current: 0.73

During the past 5 years, Zylox-Tonbridge Medical Technology Co's highest Days Sales Outstanding was 75.19. The lowest was 0.59. And the median was 0.82.

FRA:818's Days Sales Outstanding is ranked better than
99.63% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.14 vs FRA:818: 0.73

Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding declined from Jun. 2023 (0.80) to Jun. 2024 (0.75).


Zylox-Tonbridge Medical Technology Co Days Sales Outstanding Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Days Sales Outstanding Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
75.20 7.67 0.58 0.80 0.78

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.65 0.80 0.66 0.75

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding falls into.



Zylox-Tonbridge Medical Technology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.137 + 0.152) / 2 ) / 67.778*365
=0.1445 / 67.778*365
=0.78

Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding (Q: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (0.152 + 0.235) / 2 ) / 46.867*365 / 2
=0.1935 / 46.867*365 / 2
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zylox-Tonbridge Medical Technology Co  (FRA:818) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Zylox-Tonbridge Medical Technology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Zylox-Tonbridge Medical Technology Co Business Description

Traded in Other Exchanges
Address
270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines